Mark J. Antonino

3.4k total citations · 1 hit paper
37 papers, 2.4k citations indexed

About

Mark J. Antonino is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Internal Medicine. According to data from OpenAlex, Mark J. Antonino has authored 37 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Cardiology and Cardiovascular Medicine, 15 papers in Surgery and 9 papers in Internal Medicine. Recurrent topics in Mark J. Antonino's work include Antiplatelet Therapy and Cardiovascular Diseases (29 papers), Venous Thromboembolism Diagnosis and Management (9 papers) and Coronary Interventions and Diagnostics (8 papers). Mark J. Antonino is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (29 papers), Venous Thromboembolism Diagnosis and Management (9 papers) and Coronary Interventions and Diagnostics (8 papers). Mark J. Antonino collaborates with scholars based in United States, Austria and Denmark. Mark J. Antonino's co-authors include Kevin P. Bliden, Paul A. Gurbel, Udaya S. Tantry, Joseph DiChiara, Anand Singla, Cheryl Wei, Robert F. Storey, Kathleen Butler, Renli Teng and Thomas Suarez and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Mark J. Antonino

37 papers receiving 2.4k citations

Hit Papers

Randomized Double-Blind Assessment of the ONSET and OFFSE... 2009 2026 2014 2020 2009 250 500 750

Peers

Mark J. Antonino
Kirk E. Guyer United States
Heleen Bouman Netherlands
Tanja Morath Germany
Nicoline J. Breet Netherlands
Francesco Franchi United States
Joseph DiChiara United States
Young‐Hoon Jeong South Korea
Kirk E. Guyer United States
Mark J. Antonino
Citations per year, relative to Mark J. Antonino Mark J. Antonino (= 1×) peers Kirk E. Guyer

Countries citing papers authored by Mark J. Antonino

Since Specialization
Citations

This map shows the geographic impact of Mark J. Antonino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark J. Antonino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark J. Antonino more than expected).

Fields of papers citing papers by Mark J. Antonino

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark J. Antonino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark J. Antonino. The network helps show where Mark J. Antonino may publish in the future.

Co-authorship network of co-authors of Mark J. Antonino

This figure shows the co-authorship network connecting the top 25 collaborators of Mark J. Antonino. A scholar is included among the top collaborators of Mark J. Antonino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark J. Antonino. Mark J. Antonino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guha, Suvajyoti, et al.. (2020). Technical considerations for medical device manufacturers when designing gastrostomy tubes (G-tubes) using the new ISO 80369-3 connector. PLoS ONE. 15(7). e0236644–e0236644. 1 indexed citations
2.
Marrone, April K., et al.. (2017). The Regulatory Perspectives on Endoscopic Devices for Obesity. Gastrointestinal Endoscopy Clinics of North America. 27(2). 327–341. 3 indexed citations
3.
Singla, Anand, Kevin P. Bliden, Udaya S. Tantry, et al.. (2012). Abstract 15997: First Report of a Dose Dependent Effect of Statin Therapy on Urinary 11-dehydrothromboxane Br2 rLevels: A New Marker for Personalizing Statin Therapy. Circulation. 126. 1 indexed citations
4.
Singla, Anand, Kevin P. Bliden, Young‐Hoon Jeong, et al.. (2012). Platelet reactivity and thrombogenicity in postmenopausal women. Menopause The Journal of The North American Menopause Society. 20(1). 57–63. 18 indexed citations
5.
Jeong, Young‐Hoon, Kevin P. Bliden, Mark J. Antonino, et al.. (2012). Usefulness of the VerifyNow P2Y12 assay to evaluate the antiplatelet effects of ticagrelor and clopidogrel therapies. American Heart Journal. 164(1). 35–42. 69 indexed citations
6.
Gurbel, Paul A., et al.. (2011). FIRST VALIDATION OF POINT-OF-CARE CYP2C19 GENETIC TESTING IN PATIENTS UNDERGOING CORONARY ANGIOGRAPHY WITH THE VERIGENE NUCLEIC ACID ASSAY. Journal of the American College of Cardiology. 57(14). E1295–E1295. 1 indexed citations
7.
Jeong, Young‐Hoon, Kevin P. Bliden, Mark J. Antonino, Udaya S. Tantry, & Paul A. Gurbel. (2011). FIRST COMPARISON OF THROMBOELASTOGRAPHY VERSUS LIGHT TRANSMITTANCE AGGREGOMETRY TO DEFINE HIGH PLATELET REACTIVITY. Journal of the American College of Cardiology. 57(14). E1506–E1506. 1 indexed citations
8.
Gurbel, Paul A., Kevin P. Bliden, John G. Fort, et al.. (2011). Pharmacodynamic Evaluation of Clopidogrel Plus PA32540: The Spaced PA32540 With Clopidogrel Interaction Gauging (SPACING) Study. Clinical Pharmacology & Therapeutics. 90(6). 860–866. 6 indexed citations
9.
Gurbel, Paul A., Kevin P. Bliden, Mark J. Antonino, et al.. (2010). Abstract 19956: Differential Effects of Clopidogrel on Platelet Activation Measured by Annexin Binding vs. Platelet Aggregation: An Explanation for Rapid Antithrombotic Properties Even in the Presence of Clopidogrel "Resistance". Circulation. 122. 1 indexed citations
10.
Gurbel, Paul A., Udaya S. Tantry, Mark J. Antonino, et al.. (2010). THE INFLUENCE OF CYTOCHROME P450 2C19*2 AND*17 GENOTYPE, DIPLOTYPE AND METABOLIZER STATUS ON PLATELET REACTIVITY IN PATIENTS ON MAINTENANCE CLOPIDOGREL THERAPY. Journal of the American College of Cardiology. 55(10). A130.E1220–A130.E1220. 2 indexed citations
11.
Gurbel, Paul A., Kevin P. Bliden, Joseph DiChiara, et al.. (2010). Adenosine diphosphate–induced platelet-fibrin clot strength: A new thrombelastographic indicator of long-term poststenting ischemic events. American Heart Journal. 160(2). 346–354. 132 indexed citations
12.
Gurbel, Paul A., Kevin P. Bliden, Mark J. Antonino, et al.. (2009). Abstract 5901: The Effect of Ticagrelor in Stable Coronary Artery Disease Patients Nonresponsive to Clopidogrel: The RESPOND Study. Circulation. 120. 3 indexed citations
13.
Antonino, Mark J., Elisabeth Mahla, Kevin P. Bliden, Udaya S. Tantry, & Paul A. Gurbel. (2009). Effect of Long-Term Clopidogrel Treatment on Platelet Function and Inflammation in Patients Undergoing Coronary Arterial Stenting. The American Journal of Cardiology. 103(11). 1546–1550. 41 indexed citations
14.
Antonino, Mark J., Rosa Coppolecchia, Elisabeth Mahla, et al.. (2009). Antiplatelet effects of aspirin with phytosterols: Comparison with non-enteric coated aspirin alone. Thrombosis Research. 126(5). 384–385. 4 indexed citations
15.
Gurbel, Paul A., Kevin P. Bliden, Rolf P. Kreutz, et al.. (2009). The link between heightened thrombogenicity and inflammation: Pre-procedure characterization of the patient at high risk for recurrent events after stenting. Platelets. 20(2). 97–104. 36 indexed citations
16.
Gurbel, Paul A., Kevin P. Bliden, Jorge F. Saucedo, et al.. (2009). Bivalirudin and Clopidogrel With and Without Eptifibatide for Elective Stenting: Effects on Platelet Function, Thrombelastographic Indexes, and Their Relation to Periprocedural Infarction. Journal of the American College of Cardiology. 53(8). 648–657. 55 indexed citations
17.
Gurbel, Paul A., Mark J. Antonino, & Udaya S. Tantry. (2009). Recent developments in clopidogrel pharmacology and their relation to clinical outcomes. Expert Opinion on Drug Metabolism & Toxicology. 5(8). 989–1004. 58 indexed citations
18.
Singla, Anand, Mark J. Antonino, Kevin P. Bliden, Udaya S. Tantry, & Paul A. Gurbel. (2009). The relation between platelet reactivity and glycemic control in diabetic patients with cardiovascular disease on maintenance aspirin and clopidogrel therapy. American Heart Journal. 158(5). 784.e1–784.e6. 55 indexed citations
19.
Bliden, Kevin P., Joseph DiChiara, Anand Singla, et al.. (2008). The Association of Cigarette Smoking With Enhanced Platelet Inhibition by Clopidogrel. Journal of the American College of Cardiology. 52(7). 531–533. 174 indexed citations
20.
Gurbel, Paul A., Mark J. Antonino, Kevin P. Bliden, et al.. (2008). Platelet reactivity to adenosine diphosphate and long-term ischemic event occurrence following percutaneous coronary intervention: A potential antiplatelet therapeutic target. Platelets. 19(8). 595–604. 90 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026